Vimarsana
Biggest News Aggregation in the World

Page 17 - Loss Attributable News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Loss Attributable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Loss Attributable Today - Breaking & Trending Today

Oil-Dri Announces Record Financial Results for the Fourth Quarter and Fiscal Year 2023 - Vimarsana News

Oil-Dri Announces Record Financial Results for the Fourth Quarter and Fiscal Year 2023

12.10.2023 - CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) - Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its fourth quarter and fiscal year 2023.  Fourth QuarterYear to Date(in thousands, ...

VOXX International Corporation Reports its Fiscal 2024 Second Quarter Financial Results - Vimarsana News

VOXX International Corporation Reports its Fiscal 2024 Second Quarter Financial Results

/PRNewswire/ -- VOXX International Corporation (NASDAQ: VOXX), a leading manufacturer and distributor of automotive and consumer technologies for the global...

LET Group Holdings Limited Reports Interim Results For 1H 2023 - Vimarsana News

LET Group Holdings Limited Reports Interim Results For 1H 2023

<h4><i>Updates On Project Developments And Outlook</i></h4><p/>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach</a> - 29 August 2023 - LET Group Holdings Limited ("LET", the "Group" or "Company") (Hong Kong Stock Exchange code: 1383) today reported financial data for the first half of the year ending 30 June 2023.

So-Young Reports Unaudited Second Quarter 2023 Financial Results - Vimarsana News

So-Young Reports Unaudited Second Quarter 2023 Financial Results

BEIJING, Aug. 21, 2023 /PRNewswire/ -- So-Young International Inc. , the largest and most vibrant social community in China for consumers, professionals and service providers in the medical...

ZyVersa Therapeutics Reports Second Quarter 2023 Corporate and Financial Results - Vimarsana News

ZyVersa Therapeutics Reports Second Quarter 2023 Corporate and Financial Results

Key Highlights: Advanced clinical development initiatives for Cholesterol Efflux Mediator™ VAR 200, with planned initiation of a Phase 2a clinical trial in diabetic kidney disease in the first...